You can buy or sell VNDA and other stocks, options, and ETFs commission-free!
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC. The listed name for VNDA is Vanda Pharmaceuticals Inc. Common Stock.
Mihael Hristos Polymeropoulos
Washington, District of Columbia
52 Week High
52 Week Low
— per share
Expected Feb 23, After Hours